Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO

Links shared publicly online about this topic.

  • 284
    total visits

Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO

medicalnewstoday.com

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin&

View full resource at medicalnewstoday.com

Tags: Skin, Cancer, Lung Cancer, Ovarian Cancer, Lung, Women's Health, Roche Pharmaceuticals, Genentech

  • Share

Most Recently Shared on May 18, 2011 at 3:54 pm By:

OvarianCancer_ Ovarian Cancer OW

Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO: Genentech, a membe... http://bit.ly/ikFF56

1 year ago...

Also Shared By:

Lung Cancer OW Lung Cancer OW

Skin Cancer OW Skin Cancer OW

Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO

medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin&View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 18, 2011 at 12:05 pm By:

mnt_ovariancanc MNT Ovarian Cancer Health News

Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO http://mnt.to/3W2Y #ovariancancer

1 year ago...

Roche to present significant progress in advanced skin, lung and ovarian cancers at ASCO(4)

manufacturing.net — “Progress in advanced skin and lung cancers through personalised healthcare. New Phase III data for Avastin in ovarian cancer to be presentedView full resource at manufacturing.net

  • View Related
  • Share

Most Recently Shared on May 18, 2011 at 9:52 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Roche to present significant progress in advanced skin, lung and ovarian cancers at ASCO(4): Progress in advance... http://bit.ly/lyectS

1 year ago...

Genentech to Present Significant Progress in Advanced Skin, Lung and Ovarian Cancers at ASCO | Business Wire

businesswire.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data showing new personalized approaches for people with skiView full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on May 18, 2011 at 9:52 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Genentech to Present Significant Progress in Advanced Skin, Lung and Ovarian Cancers at ASCO: SOUTH SAN FRANCISC... http://bit.ly/itGf7e

1 year ago...

Genentech: Newsroom: Press Releases: News Release May 17, 2011

gene.com — “Genentech: Newsroom: Press Releases: News Release May 17, 2011View full resource at gene.com

  • View Related
  • Share

Most Recently Shared on May 18, 2011 at 5:02 am By:

genentechnews Genentech Pharma

Genentech to present significant data in advanced skin, lung and ovarian cancers at #ASCO11 http://bit.ly/ms9GIG

1 year ago...

Advertisement